🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

73 results for “Rhythm Pharmaceuticals Netherlands B.V.” Clear

  1. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Overweight and Obesity

    phase 2 small molecule completed

    1 trial

  2. Single Site Pacing

    Rhythm Pharmaceuticals Netherlands B.V.

    Acute Myocardial Infarction

    phase 2 other completed

    1 trial

  3. Tideglusib

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmogenic Cardiomyopathy

    phase 2 small molecule active

    1 trial

  4. Ablation procedure and/or cardioversion

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    phase 1 other completed

    1 trial

  5. Baroreceptor Stimulation

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypertension

    phase 1 other completed

    1 trial

  6. Bupivacaine alone OR Bupivacaine-Ketorolac-Ketamine (BKK) Combination

    Rhythm Pharmaceuticals Netherlands B.V.

    Pain Management

    phase 1 small molecule active

    1 trial

  7. Cardiac Resynchronization Therapy

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 1 other completed

    1 trial

  8. MARVEL algorithm

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrioventricular Conduction Block

    phase 1 other completed

    1 trial

  9. Pacing Lead

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 1 other completed

    1 trial

  10. Placebo

    Rhythm Pharmaceuticals Netherlands B.V.

    Obesity

    phase 1 small molecule completed

    1 trial

  11. RM-493

    Rhythm Pharmaceuticals Netherlands B.V.

    Overweight

    phase 1 small molecule completed

    1 trial

  12. Setmelanotide

    Rhythm Pharmaceuticals Netherlands B.V.

    Renal Insufficiency

    phase 1 small molecule completed

    1 trial

  13. Vagal Nerve Stimulation

    Rhythm Pharmaceuticals Netherlands B.V.

    Inflammation

    phase 1 other completed

    1 trial

  14. Ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other terminated

    1 trial

  15. Access Arm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  16. Anti-Arrhythmics

    Rhythm Pharmaceuticals Netherlands B.V.

    Arrhythmia, Cardiac

    approved small molecule terminated

    1 trial

  17. Arctic Front Advance Cardiac CryoAblation system

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    approved other completed

    1 trial

  18. CG Future Annuloplasty Ring/Band

    Rhythm Pharmaceuticals Netherlands B.V.

    Mitral Valve Insufficiency

    approved other completed

    1 trial

  19. CRT

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  20. CRT + AOP

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  21. CRT-P or CRT-D Device

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure, Congestive

    approved other terminated

    1 trial

  22. CareLink Remote Monitoring

    Rhythm Pharmaceuticals Netherlands B.V.

    Pacemaker

    approved other completed

    1 trial

  23. Conducted AF-Response Algorithm (CAFR) On

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other terminated

    1 trial

  24. DOAC

    Rhythm Pharmaceuticals Netherlands B.V.

    Ventricular Tachycardia

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources